1. O-010Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program. (20th June 2018) Authors: Moehler, M; Maderer, A; Thuss-Patience, P; Brenner, B; Hecker, J; Muñoz, F Longo; Meiler, J; Ettrich, T; Hofheinz, R; Al-Batran, S; Vogel, A; Mueller, L; Lutz, M; Borchert, K; Greil, R; Alsina, M; Karatas, A; Van Cutsem, E; Keller, R; Larcher-Senn, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗